Kalender
Berita
Pasar
Komoditas
Indeks
Saham
Mata Uang
Kripto
Obligasi
Indikator
Negara-negara
Prakiraan
Komoditas
Indeks
Mata Uang
Kripto
Obligasi
Negara-negara
Indikator
Kalender
Berita
Pasar
Komoditas
Indeks
Saham
Mata Uang
Kripto
Obligasi
Pendapatan
Liburan
Negara-negara
Amerika Serikat
Inggris Raya
Kawasan Euro
Australia
Kanada
Jepang
Tiongkok
Brazil
Rusia
India
Selanjutnya Negara-negara
Indikator
Tingkat Bunga
Tingkat Inflasi
Tingkat Pengangguran
Pertumbuhan PDB (q-to-q)
Pdb Per Kapita
Transaksi Berjalan
Cadangan Emas
Utang Pemerintah
Produksi Minyak Mentah
Harga Bensin
Peringkat Kredit
Selanjutnya Indikator
Prakiraan
Komoditas
Indeks
Mata Uang
Kripto
Obligasi
Negara-negara
Indikator
Apps
App Store
Google Play
Twitter
Light
Dark
System
Revvity | PKI - Laba Operasional
Keuangan
Harga Saham
USD 145.22
Aktiva
USD 11.49B
Kas Dan Setara
USD 592.8M
Biaya Penjualan
USD 310.32M
Aset Lancar
USD 1.86B
Kewajiban Lancar
USD 701.48M
UTANG
USD 2.63B
Dividen - Hasil
0.19
EBIT
USD 124.63M
EBITDA
USD 227.55M
Karyawan
11K
Eps Laba Per Saham
USD 1.37
Modal Dan Cadangan
USD 7.23B
Laba Kotor Pada Penjualan
USD 418.58M
Beban Bunga Utang
USD 20.81M
Pendapatan Bunga
USD -22.99M
Modal Pinjaman
USD 2.63B
Kapitalisasi Pasar
USD 18.5B
Batas Pemasukan
USD 62.3M
Biaya Operasional
USD 604.27M
Laba Operasional
USD 124.63M
Modal Saham Biasa
USD 111.59M
Pe Harga Untuk Laba
56.86
Laba Sebelum Pajak
USD 187.24M
Pendapatan Penjualan
USD 729M
Beban Penjualan Dan Administrasi
USD 275.33M
Saham
USD 388.85M
Kreditur Perdagangan
USD 163.27M
Debitur Perdagangan
USD 687.33M
Laba Operasional
Perubahan
Tanggal
Agilent
USD 444M
45M
2026-06
Align Technology
USD 193.04M
1.72M
2026-09
Bio Techne
USD 55.82M
39.18M
2026-09
Bio-Rad Laboratories
USD 72.6M
38.5M
2026-06
Bruker
USD 83.5M
13.9M
2026-09
Celltrion
KRW 19.31B
6.4B
2026-06
Charles River Laboratories
USD 202.64M
82.75M
2026-09
Cspc Pharmaceutical
CNY 206.26M
1.02B
2025-12
Danaher
USD 1.25B
118M
2026-09
Dentsply International
USD 38M
46M
2026-09
Deva Holding AS
TRY 964.87M
240.32M
2023-09
Dianthus Therapeutics
USD -61.48M
14.95M
2026-06
Divis Laboratories Ltd
INR 14.24B
2.95B
2026-09
Edwards Lifesciences
USD 542.7M
23.2M
2026-09
Illumina
USD 305M
45M
2026-09
Intuitive Surgical
USD 1.05B
69.9M
2026-09
IQVIA Holdings
USD 608M
1.99B
2026-09
Kangmei Pharma
CNY -35.26M
24.32M
2026-06
Knight Therapeutics
CAD 6.21M
3.27M
2025-12
Laboratorios Farma
EUR 135.05M
49.84M
2023-12
Laboratory Of America
USD 418M
38.7M
2026-09
Malin Corporation
EUR -1.1M
400K
2024-12
Medical Developments International
AUD -36K
444K
2025-12
Mesa Laboratories
USD 5.78M
2.27M
2024-12
Mettler Toledo International
USD 287.55M
53.61M
2026-06
Myriad Genetics
USD -3M
20.3M
2025-12
Neuren Pharmaceuticals
AUD 17.01M
11.56M
2025-12
OraSure Technologies
USD -13.59M
2.13M
2025-12
Organigram Holdings
CAD 5.33M
15.12M
2026-06
Ovoca Bio
EUR -173K
990K
2025-12
Pacific Biosciences Of California
USD -53.19M
35.08M
2025-12
Pharma Mar
EUR 7.65M
9.06M
2026-09
Qiagen NV
USD 141.4M
24.77M
2026-06
Quest Diagnostics
USD 479M
20M
2026-09
Quidel
USD 12.1M
27.4M
2026-09
Repligen
USD 24.31M
3.18M
2026-09
Revvity
USD 124.63M
1.51M
2026-09
Sartorius
EUR 179.8M
15.8M
2026-09
Sino Biopharmaceutical
CNY 5.18B
3.32B
2025-06
Thermo Fisher Scientific
USD 2.46B
277M
2026-09
Tilray
USD -20.01M
9.34M
2025-09
Waters
USD -86M
234M
2026-06
Zealand Pharma A/S
-539M
168.05M
2026-03
Zz Pientze Pharmaceu
CNY 222.81M
140.02M
2026-09
×